Key Figures
| Multi-year comparison MedCap group | 2020 | 2019 | 2018 | 2017* | 2016/2017 | 2015/2016 | 2014/2015 | 2013/2014 |
| Net Sales, MSEK | 817,4 | 757,1 | 709,0 | 411,2 | 851,7 | 816,9 | 852,8 | 826,1 |
| EBITDA, MSEK | 157,2 | 140,0 | 77,6 | 41,5 | 30,3 | 55,3 | 31,0 | 55,4 |
| Equity/assets ratio | 55% | 39% | 41% | 44% | 48% | 48% | 49% | 35% |
| Equity/share (SEK) | 40,3 | 24,2 | 20,2 | 19,8 | 21,0 | 21,0 | 19,9 | 17,3 |
| Market price/share (SEK) | 230,0 | 139,0 | 79,4 | 45,0 | 30,5 | 30,5 | 27,6 | 42,5 |
| 8 months (1 May - 31 August | ||||||||
Become a part of MedCap
Here you will find more information about our investment strategy and about MedCap as owner.